A New Roadmap for Drug Development for Alzheimer's Disease

Overview

Journal Nat Rev Drug Discov

Specialty Pharmacology

Date 2013 Dec 24

PMID 24362362

Citations 32

Authors

Robert E Becker

Nigel H Greig

Ezio Giacobini

Lon S Schneider

Luigi Ferrucci

Affiliations

Soon will be listed here.

Citing Articles

Development of quantitative detection methods for four Alzheimer's disease specific biomarker panels using electrochemical immunosensors based on enzyme immunoassay.

Park I, Choi Y, Jo S Anal Sci. 2024; 40(10):1809-1821.

PMID: 38884905 DOI: 10.1007/s44211-024-00614-7.

GS-SMD server for steered molecular dynamics of peptide substrates in the active site of the γ-secretase complex.

Orzel U, Pasznik P, Miszta P, Lorkowski M, Niewieczerzal S, Jakowiecki J Nucleic Acids Res. 2023; 51(W1):W251-W262.

PMID: 37207343 PMC: 10320170. DOI: 10.1093/nar/gkad409.

Compromised autophagy and mitophagy in brain ageing and Alzheimer's diseases.

Caponio D, Veverova K, Zhang S, Shi L, Wong G, Vyhnalek M Aging Brain. 2023; 2:100056.

PMID: 36908880 PMC: 9997167. DOI: 10.1016/j.nbas.2022.100056.

Current progress, challenges and future prospects of diagnostic and therapeutic interventions in Alzheimer's disease.

Rajasekhar K, Govindaraju T RSC Adv. 2022; 8(42):23780-23804.

PMID: 35540246 PMC: 9081849. DOI: 10.1039/c8ra03620a.

Novel and Potential Small Molecule Scaffolds as DYRK1A Inhibitors by Integrated Molecular Docking-Based Virtual Screening and Dynamics Simulation Study.

Shahroz M, Sharma H, Altamimi A, Alamri M, Ali A, Ali A Molecules. 2022; 27(4).

PMID: 35208955 PMC: 8875901. DOI: 10.3390/molecules27041159.

References

Buchhave P, Minthon L, Zetterberg H, Wallin A, Blennow K, Hansson O . Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia. Arch Gen Psychiatry. 2012; 69(1):98-106. DOI: 10.1001/archgenpsychiatry.2011.155. View

Ness S, Rafii M, Aisen P, Krams M, Silverman W, Manji H . Down's syndrome and Alzheimer's disease: towards secondary prevention. Nat Rev Drug Discov. 2012; 11(9):655-6. DOI: 10.1038/nrd3822. View

Rodrigue K, Kennedy K, Devous Sr M, Rieck J, Hebrank A, Diaz-Arrastia R . β-Amyloid burden in healthy aging: regional distribution and cognitive consequences. Neurology. 2012; 78(6):387-95. PMC: 3280058. DOI: 10.1212/WNL.0b013e318245d295. View

Reiman E, Langbaum J, Tariot P . Alzheimer's prevention initiative: a proposal to evaluate presymptomatic treatments as quickly as possible. Biomark Med. 2010; 4(1):3-14. PMC: 2850446. DOI: 10.2217/bmm.09.91. View

Reiman E, Langbaum J, Fleisher A, Caselli R, Chen K, Ayutyanont N . Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments. J Alzheimers Dis. 2011; 26 Suppl 3:321-9. PMC: 3343739. DOI: 10.3233/JAD-2011-0059. View

Mullard A . Sting of Alzheimer's failures offset by upcoming prevention trials. Nat Rev Drug Discov. 2012; 11(9):657-60. DOI: 10.1038/nrd3842. View

Morris J, Aisen P, Bateman R, Benzinger T, Cairns N, Fagan A . Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer Network. Clin Investig (Lond). 2012; 2(10):975-984. PMC: 3489185. DOI: 10.4155/cli.12.93. View

Aisen P, Vellas B, Hampel H . Moving towards early clinical trials for amyloid-targeted therapy in Alzheimer's disease. Nat Rev Drug Discov. 2013; 12(4):324. DOI: 10.1038/nrd3842-c1. View

Pike K, Ellis K, Villemagne V, Good N, Chetelat G, Ames D . Cognition and beta-amyloid in preclinical Alzheimer's disease: data from the AIBL study. Neuropsychologia. 2011; 49(9):2384-90. DOI: 10.1016/j.neuropsychologia.2011.04.012. View

10.

Vellas B, Carrillo M, Sampaio C, Brashear H, Siemers E, Hampel H . Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force. Alzheimers Dement. 2013; 9(4):438-44. DOI: 10.1016/j.jalz.2013.03.007. View

11.

Becker R, Greig N . Lost in translation: neuropsychiatric drug development. Sci Transl Med. 2010; 2(61):61rv6. PMC: 5178822. DOI: 10.1126/scitranslmed.3000446. View